Hims & Hers Sees Stock Surge Amid Trump’s FDA Appointment Speculations

In a significant development in the healthcare and wellness sector, shares of Hims & Hers Health Inc. experienced a notable rise following the news of former President Donald Trump’s likely appointment of a new FDA chief, who is perceived as a potential supporter of the company’s business model. This surge has sparked considerable interest among investors and analysts alike, reflecting optimism about future growth and regulatory alignment.

Continue reading

Walmart to Launch Prescription Delivery Service, Taking on Amazon's Healthcare Push

In a strategic move to enhance its competitive stance against Amazon, Walmart has announced plans to roll out a prescription delivery service. This initiative comes as part of the retail giant's ongoing effort to provide more comprehensive healthcare solutions to its customers and to capture a larger share of the burgeoning online pharmacy market.

Continue reading